MARKET WIRE NEWS

AdvisorShares Announces NAV Restatement for the AdvisorShares MSOS Daily Leveraged ETF (MSOX)

MWN-AI** Summary

AdvisorShares has announced a restatement of the net asset value (NAV) per share for the AdvisorShares MSOS Daily Leveraged ETF (MSOX) following an accounting error by the Fund Administrator. The error involved incorrect income accruals related to total return swaps held from December 22, 2025, through February 2, 2026. The NAVs have been adjusted across specific dates in that timeframe, notably reflecting differences that ranged from minor to significant variations.

The NAV adjustment took effect after the market closed on March 6, 2026. The company swiftly directed the Fund Administrator to address and rectify the issue upon notification. Enhanced control measures and review processes for income accrual accounting have been implemented to prevent future occurrences. In addition, the independent auditors of the Fund have been informed, and AdvisorShares has committed to ongoing monitoring of the Administrator's corrective actions.

MSOX employs a daily leveraged investment strategy aimed at experienced and sophisticated investors, typically targeting approximately double the exposure of its underlying index, the US Cannabis ETF (MSOS). However, potential investors are reminded of the inherent risks associated with leveraged ETFs, where a single day's market movement can result in substantial losses.

Investors with inquiries regarding the NAV restatement are encouraged to reach out to AdvisorShares Investor Relations. The firm underscores its commitment to transparency and will continue to provide updates as necessary. As emphasized, the ETF's design necessitates active monitoring and management by investors, making it suitable primarily for those well-versed in the dynamics of leveraged trading.

MWN-AI** Analysis

The recent announcement by AdvisorShares regarding the restatement of the net asset value (NAV) for the AdvisorShares MSOS Daily Leveraged ETF (MSOX) is a critical trading signal for investors, particularly those involved in the high-volatility cannabis sector. The NAV correction stems from an accounting error related to income accruals tied to total return swaps held by the fund. This mismanagement highlights the importance of accurate financial oversight in leveraged ETFs, which are designed for the sophisticated and active investor.

With MSOX's objective to provide approximately double the returns of benchmark cannabis assets on a daily basis, any misstep in NAV can lead to heightened volatility and potential mispricing. It’s essential for investors looking at MSOX to understand that such leveraged instruments can diverge significantly from their targets due to various factors, including market fluctuations and the very mechanism of their derivation via swaps.

For those considering an entry or addition to their portfolio in MSOX following this announcement, it is prudent to approach with caution. The leveraged structure amplifies both performance and risks—any sudden market moves could lead to rapid losses equal to or exceeding the invested capital in a single trading day.

Furthermore, the correction demonstrates enhanced scrutiny regarding the fund's financial practices in the future. On the upside, if the underlying cannabis-market dynamics are favorable, MSOX can benefit from sharp gains, potentially reflecting the sector’s growth. However, investors should conduct thorough due diligence and ensure they have a solid risk management strategy in place due to the inherent volatility of leveraged products, particularly in niche sectors like cannabis.

Ultimately, while there may be opportunities for significant gains, the risk factors necessitate careful monitoring and a keen understanding of the unique attributes of leveraged ETFs.

**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.

Source: PR Newswire

PR Newswire

Restatement Reflects Correction of Income Accrual Accounting for Total Return Swaps

BETHESDA, Md., March 6, 2026 /PRNewswire/ -- AdvisorShares announced that the previously disclosed net asset value (NAV) per share of the AdvisorShares MSOS Daily Leveraged ETF (NYSE Arca: MSOX) has been restated due to the Fund Administrator not correctly accounting for income accruals for some of the total return swaps held from December 22, 2025, through February 2, 2026.

Effective after market close on March 6, 2026, the NAV has been restated as follows:

Effective Date   

Reported   
NAV

Adjusted   
NAV

12/22/2025

4.18133

4.15513

12/23/2025

4.50704

4.47946

12/24/2025

4.56226

4.53424

12/26/2025

4.67592

4.64579

12/29/2025

3.98719

3.95385

12/30/2025

4.43700

4.40373

12/31/2025

4.46372

4.42948

1/2/2026

4.59906

4.56264

1/20/2026

4.07064

4.04940

1/21/2026

3.99525

3.97294

1/22/2026

4.16918

4.14587

1/23/2026

4.55681

4.53364

1/26/2026

4.07368

4.04718

1/27/2026

3.70599

3.67840

1/28/2026

3.53807

3.50948

1/29/2026

3.24178

3.21226

1/30/2026

3.14766

3.11730

2/2/2026

3.23646

3.20382

Upon being notified of this error, AdvisorShares acted promptly to direct the Fund Administrator to investigate, quantify, and correct the error. The Fund Administrator has implemented enhanced controls and review procedures for income accrual accounting on total return swaps. The Fund's independent auditors have been notified. AdvisorShares will continue to monitor the Fund Administrator's remediation efforts and will provide further updates as appropriate.

Shareholders with questions regarding the restatement are encouraged to contact AdvisorShares Investor Relations at 1-877-843-3831 or visit www.advisorshares.com.

MSOX has a daily leveraged investment objective and is designed for experienced and sophisticated traders only. While the investment objective is still designed to target approximately two times the exposure of MSOS on a daily basis, MSOX will typically be in range above or below the two times leverage target. This ETF was built to provide more liquidity to these companies in this growing industry, but it's important for investors to remember this ETF is designed only for experienced and sophisticated active day trading investors. Please read the MSOX prospectus for all the risks associated with this ETF.

About AdvisorShares
AdvisorShares is a leading provider of actively managed exchange-traded funds (ETFs), including a suite of cannabis-focused ETFs designed to provide investors with global, domestic, and leveraged exposure to the cannabis industry. AdvisorShares is committed to transparency, investor protection, and delivering innovative investment solutions.

For financial professionals and investors requesting more information, call 1-877-843-3831 or visit www.advisorshares.com. Follow @AdvisorShares on X (Twitter) and LinkedIn for more insights. 

Forward-Looking Statements and Important Disclosures
This press release contains forward-looking statements within the meaning of the federal securities laws. These statements are based on management's current expectations and assumptions and are subject to risks, uncertainties, and other factors that could cause actual results to differ materially from those described. Forward-looking statements include, without limitation, statements regarding corrective actions, future procedures, and anticipated outcomes of the NAV restatement review. AdvisorShares undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.

This press release does not constitute an admission of liability or wrongdoing by AdvisorShares Investments, LLC, the AdvisorShares MSOS Daily Leveraged ETF, or any of their respective officers, directors, employees, or agents. AdvisorShares expressly disclaims any liability arising from or related to the Fund Administrator's accounting error. Responsibility for the accurate calculation and reporting of the Fund's NAV is contractually vested in the Fund Administrator, and any losses, claims, damages, or expenses arising from this error are solely the responsibility of the Fund Administrator.

Before investing you should carefully consider the Fund's investment objectives, risks, charges and expenses. This and other information is in the prospectus, a copy of which may be obtained by visiting www.advisorshares.com. Please read the prospectus carefully before you invest. Foreside Fund Services, LLC, distributor.

The Fund is not suitable for all investors. The Fund is designed to be utilized only by knowledgeable investors who understand the potential consequences of seeking daily 2x investment results, understand the risks associated with the use of leverage, and are willing to monitor their portfolios frequently. The Fund is not intended to be used by, and is not appropriate for, investors who do not intend to actively monitor and manage their portfolios. An investor could lose the full principal value of their investment within a single day.

The Fund is an actively managed ETF that seeks to provide investment results that are approximately two times (2x) the daily total return, before fees and expenses, of the US Cannabis ETF, an affiliated ETF, by entering into one or more swaps agreements on the US Cannabis ETF. The Fund does not seek to achieve its stated investment objective for a period of time different than a single day. A single day is measured from the time the Fund calculates its net asset value ("NAV") to the time of the Fund's next NAV calculation. The Fund will enter into one or more swap agreements intended to produce economically-leveraged investment results relative to the returns of the US Cannabis ETF. The Fund may use a combination of swaps on the US Cannabis ETF and swaps on various investment vehicles that are designed to track the performance of the US Cannabis ETF. The Fund expects that cash balances in connection with the use of such financial instruments ("Collateral") will typically be held in money market instruments or other cash equivalents. The Fund is subject to a number of risks that may affect the value of its shares. This section provides additional information about the Fund's principal risks. The degree to which a risk applies to the Fund varies according to its investment allocation. Each investor should review the complete description of the principal risks before investing in the Fund. As with investing in other securities whose prices increase and decrease in market value, you may lose money by investing in the Fund.

Cannabis-Related Company Risk: Cannabis-related companies are subject to various laws and regulations that may differ at the state/local and federal level. These laws and regulations may (i) significantly affect a cannabis-related company's ability to secure financing, (ii) impact the market for marijuana industry sales and services, and (iii) set limitations on marijuana use, production, transportation, and storage. Cannabis-related companies may also be required to secure permits and authorizations from government agencies to cultivate or research marijuana. In addition, cannabis-related companies are subject to the risks associated with the greater agricultural industry, including changes to or trends that affect commodity prices, labor costs, weather conditions, and laws and regulations related to environmental protection, health and safety. Cannabis-related companies may also be subject to risks associated with the biotechnology and pharmaceutical industries. These risks include increased government regulation, the use and enforcement of intellectual property rights and patents, technological change and obsolescence, product liability lawsuits, and the risk that research and development may not necessarily lead to commercially successful products.

Counterparty Risk – The Fund may invest in financial instruments involving counterparties that attempt to gain exposure to a particular group of securities, index or asset class without actually purchasing those securities or investments, or to hedge a position. The Fund's use of such financial instruments, including swap agreements, involves risks that are different from those associated with ordinary portfolio securities transactions. For example, if a swap agreement counterparty defaults on its payment obligations to the Fund, this default will cause the value of your investment in the Fund to decrease.

Daily Leverage Risk – Leverage increases the risk of a total loss of an investor's investment, may increase the volatility of the Fund, and may magnify any differences between the performance of the Fund and the US Cannabis ETF. Because the Fund includes a multiplier of approximately two times (2x) the US Cannabis ETF, a single day movement in the US Cannabis ETF approaching -50% at any point in the day could result in the total loss of an investor's investment, even if the US Cannabis ETF subsequently moves in an opposite direction, eliminating all or a portion of the earlier movement. This would be the case with any such single day movements in the US Cannabis ETF, even if the US Cannabis ETF maintains a level greater than zero at all times.

Derivatives Risk – Derivatives may be riskier than other types of investments because they may be more sensitive to changes in economic or market conditions than other types of investments and could result in losses that significantly exceed the Fund's original investment. A derivative is a financial contract the value of which depends on, or is derived from, the value of a financial asset (such as stock, bond or currency), a physical asset (such as gold), or a market index (such as the S&P 500 Index). Many derivatives, including the swaps in which the Fund will invest, create leverage thereby causing the Fund to be more volatile than it would be if it had not invested in derivatives. Investing in swaps also will expose the Fund to counterparty risk (the risk that the derivative counterparty will not fulfill its contractual obligations) and to credit risk (the risk that a counterparty is or is perceived to be unwilling or unable to make timely payments or otherwise meet its contractual obligations).

Shares are bought and sold at market price not net asset value (NAV) and are not individually redeemed from the Fund. Market price returns are based on the midpoint of the bid/ask spread at 4:00 pm Eastern Time (when NAV is normally determined) and do not represent the return you would receive if you traded at other times.

DEFINITIONS:
swap agreement is a derivative contract between two parties that involves the exchange of pre-agreed cash flows of two financial instruments.

SOURCE AdvisorShares

FAQ**

What specific measures is AdvisorShares implementing to prevent future accounting errors related to the NAV for the AdvisorShares MSOS 2x Daily ETF MSOX following the recent restatement?

AdvisorShares is implementing enhanced internal controls, thorough audits, and ongoing oversight of financial reporting processes to prevent future accounting errors related to the NAV for the AdvisorShares MSOS 2x Daily ETF (MSOX) following the recent restatement.

How does the NAV restatement for the AdvisorShares MSOS Daily ETF MSOX impact the overall performance and return expectations for investors in the fund?

The NAV restatement for the AdvisorShares MSOS 2x Daily ETF (MSOX) could lead to adjustments in performance metrics and return expectations for investors, reflecting updated asset valuations and potentially altering investment strategies based on perceived risks and rewards.

Can AdvisorShares provide more details on the nature of the errors in income accrual accounting for total return swaps, as it relates to the AdvisorShares MSOS 2x Daily ETF MSOX?

AdvisorShares has not publicly detailed specific errors in income accrual accounting for total return swaps related to the AdvisorShares MSOS 2x Daily ETF (MSOX), but it typically involves misestimations in projected income or timing misalignments affecting perceived returns.

In light of the NAV restatement for the AdvisorShares MSOS 2x Daily ETF MSOX, how should investors assess associated risks, particularly with regard to leverage and counterparty risk?

Investors should meticulously evaluate the inherent risks of leverage and counterparty exposure in the AdvisorShares MSOS 2x Daily ETF MSOX, particularly in light of the NAV restatement, to ensure a comprehensive understanding of potential volatility and market impact.

**MWN-AI FAQ is based on asking OpenAI questions about AdvisorShares MSOS 2x Daily ETF (NYSE: MSOX).

AdvisorShares MSOS 2x Daily ETF

NASDAQ: MSOX

MSOX Trading

0.85% G/L:

$2.7532 Last:

749,078 Volume:

$2.69 Open:

mwn-ir Ad 300

MSOX Latest News

June 21, 2025 07:34:00 pm
(MSOX) Technical Data
May 19, 2025 11:36:00 am
Long Term Trading Analysis for (MSOX)

MSOX Stock Data

$39,416,181
12,473,475
N/A
N/A
US

Subscribe to Our Newsletter

Link Market Wire News to Your X Account

Download The Market Wire News App